EMILY WHITTY: Open Payments
NPI 1215700893 · DUNDALK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$798 in 37 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,582 · 2025 $798
Food & beverage: $798
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $126 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| ABBVIE INC. | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| Lilly USA, LLC | 3 | $66 |
| Janssen Pharmaceuticals, Inc | 2 | $53 |
| PFIZER INC. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Corcept Therapeutics | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
Products named: Rybelsus, Kerendia, VRAYLAR, MOUNJARO, SPRAVATO, BREZTRI, Ozempic, Korlym.
Industry payments across MD — which companies pay providers there.
